Continuous beta-lactam infusion in critically ill patients: the clinical evidence
There is controversy over whether traditional intermittent bolus dosing or continuous infusion of beta-lactam antibiotics is preferable in critically ill patients. No significant difference between these two dosing strategies in terms of patient outcomes has been shown yet. This is despite compellin...
| Main Authors: | Abdul Aziz, Mohd. Hafiz, Dulhunty, Joel M., Bellomo, Rinaldo, Lipman, Jeffrey, Roberts, Jason A. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer-Verlag Berlin Heidelberg
2012
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/30503/ http://irep.iium.edu.my/30503/ http://irep.iium.edu.my/30503/ http://irep.iium.edu.my/30503/2/2110-5820-2-37.pdf |
Similar Items
-
Continuous versus intermittent beta-lactam infusion in severe sepsis: a meta-analysis of individual patient data from randomized trials
by: Roberts, Jason A., et al.
Published: (2016) -
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2016) -
The DALI study: defining antibiotic levels in intensive care unit patients: prolonged infusion of beta-lactam antibiotics in critically ill patients
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2013) -
Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections
by: Abdul Aziz, Mohd. Hafiz, et al.
Published: (2017) -
Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: A randomized controlled trial of continuous infusion versus intermittent bolus administration
by: Jamal, Janattul-Ain, et al.
Published: (2015)